HUP0201880A3 - Pharmaceutical composition containing sibutramine and a lipase inhibitor - Google Patents

Pharmaceutical composition containing sibutramine and a lipase inhibitor

Info

Publication number
HUP0201880A3
HUP0201880A3 HU0201880A HUP0201880A HUP0201880A3 HU P0201880 A3 HUP0201880 A3 HU P0201880A3 HU 0201880 A HU0201880 A HU 0201880A HU P0201880 A HUP0201880 A HU P0201880A HU P0201880 A3 HUP0201880 A3 HU P0201880A3
Authority
HU
Hungary
Prior art keywords
pharmaceutical composition
composition containing
lipase inhibitor
containing sibutramine
sibutramine
Prior art date
Application number
HU0201880A
Other languages
English (en)
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Publication of HUP0201880A2 publication Critical patent/HUP0201880A2/hu
Publication of HUP0201880A3 publication Critical patent/HUP0201880A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU0201880A 1999-06-24 2000-06-16 Pharmaceutical composition containing sibutramine and a lipase inhibitor HUP0201880A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9914742.3A GB9914742D0 (en) 1999-06-24 1999-06-24 Therapeutic agents
PCT/EP2000/005544 WO2001000187A2 (en) 1999-06-24 2000-06-16 Pharmaceutical composition containing sibutramine and a lipase inhibitor

Publications (2)

Publication Number Publication Date
HUP0201880A2 HUP0201880A2 (hu) 2002-12-28
HUP0201880A3 true HUP0201880A3 (en) 2003-03-28

Family

ID=10855953

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0201880A HUP0201880A3 (en) 1999-06-24 2000-06-16 Pharmaceutical composition containing sibutramine and a lipase inhibitor

Country Status (20)

Country Link
EP (1) EP1189638A2 (hu)
JP (1) JP2003503344A (hu)
KR (1) KR20020012293A (hu)
CN (1) CN1365287A (hu)
AU (1) AU5815100A (hu)
BG (1) BG106209A (hu)
BR (1) BR0011884A (hu)
CA (1) CA2376213A1 (hu)
CZ (1) CZ20014614A3 (hu)
GB (1) GB9914742D0 (hu)
HK (1) HK1050476A1 (hu)
HU (1) HUP0201880A3 (hu)
IL (1) IL147078A0 (hu)
MX (1) MXPA01013023A (hu)
NO (1) NO20016301L (hu)
PL (1) PL352387A1 (hu)
SK (1) SK18822001A3 (hu)
TR (1) TR200103704T2 (hu)
WO (1) WO2001000187A2 (hu)
ZA (1) ZA200110046B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399826B1 (en) * 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US7089666B2 (en) * 2003-06-06 2006-08-15 The Regents Of The University Of California Microfabricated vertical comb actuator using plastic deformation
CN101626768B (zh) 2006-09-15 2013-08-21 雷维瓦药品公司 环烷基甲胺的合成、使用方法和组合物
CN101890017A (zh) * 2009-05-22 2010-11-24 北京奥萨医药研究中心有限公司 含有西布曲明和他汀类降脂药物的药物组合物及其用途
WO2012003501A2 (en) 2010-07-02 2012-01-05 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
BR112014016122A8 (pt) 2011-12-30 2017-07-04 Reviva Pharmaceuticals Inc composto, e, composição farmacêutica

Also Published As

Publication number Publication date
CA2376213A1 (en) 2001-01-04
WO2001000187A3 (en) 2001-11-15
NO20016301D0 (no) 2001-12-21
MXPA01013023A (es) 2003-08-01
SK18822001A3 (sk) 2003-04-01
IL147078A0 (en) 2002-08-14
WO2001000187A2 (en) 2001-01-04
BG106209A (en) 2002-09-30
HUP0201880A2 (hu) 2002-12-28
EP1189638A2 (en) 2002-03-27
JP2003503344A (ja) 2003-01-28
HK1050476A1 (zh) 2003-06-27
AU5815100A (en) 2001-01-31
KR20020012293A (ko) 2002-02-15
GB9914742D0 (en) 1999-08-25
TR200103704T2 (tr) 2002-05-21
PL352387A1 (en) 2003-08-25
NO20016301L (no) 2001-12-21
ZA200110046B (en) 2003-03-06
CN1365287A (zh) 2002-08-21
BR0011884A (pt) 2003-08-12
CZ20014614A3 (cs) 2004-02-18

Similar Documents

Publication Publication Date Title
EP1071403A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING STATIN AND ASPIRIN
ZA98376B (en) Sulfamide-metalloprotease inhibitors
PL336625A1 (en) Protease inhibitors
GB2321641B (en) Sulfamide-metalloprotease inhibitors
PL336589A1 (en) Serinic protease inhibitors
IL133368A0 (en) Urokinase inhibitors
ZA988469B (en) Pyrrolidin-2-one compounds and their use as neuraminidase inhibitors
HUP0100427A3 (en) Ace inhibitor-mmp inhibitor combinations
IL132088A0 (en) Protease inhibitors
PL337755A1 (en) Protease inhibitors
IL132629A0 (en) Protease inhibitors
AU9640698A (en) Pharmaceutical combination of a cyclooxigenase-2 inhibitor and acetaminophen or an opiate
AU6422298A (en) Pharmaceutical composition containing a phosphorylamide and an ayntibiotic
AU9061798A (en) Protease variants and compositions
PL352387A1 (en) Pharmaceutical composition containing sibutramine and a lipase inhibitor
EP1015438A4 (en) PROTEASE INHIBITORS
HUP0001976A3 (en) Antiviral protease inhibitors and pharmaceutical compositions
GB9815925D0 (en) HIV Intergrase inhibitors
EP0975612A4 (en) PROTEASE INHIBITORS
AU9061898A (en) Protease variants and compositions
GB9907469D0 (en) Labels and manufacture thereof
ZA200100696B (en) Pharmaceutical compositions containing lipase inhibitors
GB9725783D0 (en) Inhibitors
GB9713709D0 (en) Inhibitors
GB9709064D0 (en) Inhibitors